Schedule 13D ownership disclosure

TEMPEST THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 87978U207

Event date: 2026-02-03

Filing-level shares
4,837,070.00
Percent of class
35.9%
  • Matthew AngelReported CIK 0001931356

    Shares: 4,837,070.00 · Class: 35.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001931356-26-000009
Form type
SCHEDULE 13D
Filer
Angel Matthew
CIK
CIK 1931356
Filed
Feb 10, 2026
Reporting period
Feb 03, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub